Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Wyss

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
International Orthopaedics|June 7, 2019
Fluoroscopically guided caudal epidural steroid injections for axial low back pain associated with central disc protrusions: a prospective outcome studyJames J Lee, Elizabeth T Nguyen, Julian R Harrison, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Hit-to-Lead Optimization of Non-ATP Competitive MK2 (MAPKAPK2) InhibitorsXiaohua Huang, Gerald W Shipps, Cliff C Cheng, et al.
Journal of Medicinal Chemistry|January 2, 2010
Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitorsYu-Sen Wang, Corey Strickland, Johannes H Voigt, et al.
Journal of Medicinal Chemistry|January 2, 2010
Discovery of cyclic acylguanidines as highly potent and selective beta-site amyloid cleaving enzyme (BACE) inhibitors: Part I--inhibitor design and validationZhaoning Zhu, Zhong-Yue Sun, Yuanzan Ye, et al.
Nature Communications|January 3, 2026
WRN structural flexibility showcased through fragment-based lead discovery of inhibitorsRachel L Palte, Mihir Mandal, Justyna Sikorska, et al.
Journal of Medicinal Chemistry|March 25, 2022
Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of CancerWonsuk Chang, Michael D Altman, Charles A Lesburg, et al.
Journal of Medicinal Chemistry|December 8, 2022
Rapid Evolution of a Fragment-like Molecule to Pan-Metallo-Beta-Lactamase Inhibitors: Initial Leads toward Clinical CandidatesMihirbaran Mandal, Li Xiao, Weidong Pan, et al.
Science (New York, N.Y.)|August 22, 2020
An orally available non-nucleotide STING agonist with antitumor activityBo-Sheng Pan, Samanthi A Perera, Jennifer A Piesvaux, et al.
British Journal of Sports Medicine|March 3, 2025
Recommendations for use of extracorporeal shockwave therapy in sports medicine: an international modified Delphi studyHye Chang Rhim, Mani Singh, Nicola Maffulli, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
International Orthopaedics|June 7, 2019
Fluoroscopically guided caudal epidural steroid injections for axial low back pain associated with central disc protrusions: a prospective outcome studyJames J Lee, Elizabeth T Nguyen, Julian R Harrison, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Hit-to-Lead Optimization of Non-ATP Competitive MK2 (MAPKAPK2) InhibitorsXiaohua Huang, Gerald W Shipps, Cliff C Cheng, et al.
Journal of Medicinal Chemistry|January 2, 2010
Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitorsYu-Sen Wang, Corey Strickland, Johannes H Voigt, et al.
Journal of Medicinal Chemistry|January 2, 2010
Discovery of cyclic acylguanidines as highly potent and selective beta-site amyloid cleaving enzyme (BACE) inhibitors: Part I--inhibitor design and validationZhaoning Zhu, Zhong-Yue Sun, Yuanzan Ye, et al.
Nature Communications|January 3, 2026
WRN structural flexibility showcased through fragment-based lead discovery of inhibitorsRachel L Palte, Mihir Mandal, Justyna Sikorska, et al.
Journal of Medicinal Chemistry|March 25, 2022
Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of CancerWonsuk Chang, Michael D Altman, Charles A Lesburg, et al.
Journal of Medicinal Chemistry|December 8, 2022
Rapid Evolution of a Fragment-like Molecule to Pan-Metallo-Beta-Lactamase Inhibitors: Initial Leads toward Clinical CandidatesMihirbaran Mandal, Li Xiao, Weidong Pan, et al.
Science (New York, N.Y.)|August 22, 2020
An orally available non-nucleotide STING agonist with antitumor activityBo-Sheng Pan, Samanthi A Perera, Jennifer A Piesvaux, et al.
British Journal of Sports Medicine|March 3, 2025
Recommendations for use of extracorporeal shockwave therapy in sports medicine: an international modified Delphi studyHye Chang Rhim, Mani Singh, Nicola Maffulli, et al.
Pageof 10